Reduction of share capital in Schouw & Co.

DSV, 1110 - MAJOR SHAREHOLDER ANNOUNCEMENT

Copenhagen Infrastructure Partners, KK Invest and Danish Bio Commodities to operate and develop one of Denmark's largest biogas plants

DSV, 1109 - MAJOR SHAREHOLDER ANNOUNCEMENT

Company announcement no 11/2024 - April 2024 Sales price

Photocat has agreed with Eminova to become Certified advisor for Photocat.

Q1 2024 results in line with expectations. Full-year guidance narrowed

Coloplast A/S - Invitation to Coloplast's Meet the Management event on 6 June 2024 (gentle reminder)

cBrain wins the Tax Governance Top Rating 2024 for mid cap companies

MT Højgaard Holding A/S: Continued profitable growth in a slowing market

TCM Group A/S: Interim report Q1 2024

Consolidated interim report 1 January – 31 March 2024

Zealand Pharma Announces Financial Results for the First Quarter of 2024

Nilfisk reports Q1 2024 results: Solid organic growth and robust financial performance in line with plan

Jon Sintorn will join Nilfisk as CEO on June 17, 2024

Ress Life Investments A/S: Ress Life Investments A/S publishes Net Asset Value (NAV)

RTX A/S – Holding of treasury shares

Konsolidator expands its product portfolio to include BI reporting and analytics

FLSmidth & Co. Group Interim Report for Q1 2024: Strong gross margin leading to continued improvement in profitability

Allarity Therapeutics Reports First Quarter Financial Results and Highlights, including Clear Clinical Benefits from Phase 2 Trial, NASDAQ Compliance, and Significant Improvement in Cash and Equity Balances

Genmab to Present New and Updated Results From Multiple Clinical Trials Evaluating Epcoritamab Across Various B-Cell Malignancies at the 2024 European Hematology Association (EHA) Congress

Half-year report - RIAS A/S

Interim Management Statement covering Q3 2023/24

DSV, 1108 - SHARE BUYBACK IN DSV A/S

Interim report of Copenhagen Airports A/S (CPH) for the period 1 January – 31 March 2024

Periodemeddelelse Første Kvartal 2024

Coloplast expands its Luja™ portfolio with next generation catheter for women

DFDS to Invest €1 Billion in Battery Electric Ships for the Channel

Novo Nordisk A/S: Once-weekly and once-monthly Mim8 demonstrate superior reduction of treated bleeding episodes compared to on-demand and prior prophylaxis treatment in people with haemophilia A in the Frontier 2 trial

ROCKWOOL enrols India, China, and Slovenia in Rockcycle programme

Schouw & Co. share buy-back programme, week 19 2024

Roblon announces changes to the Executive Management

C. Hasse & Sohn Announces a 5-Years License agreement to Photocat NOxOFF Technology to produce in Uelzen, Germany

MC2 Therapeutics Receives Positive Feedback from FDA pre-IND Meeting and Updates on Indication Expansion Strategy

Evaxion Receives Nasdaq Notification

General Assembly minutes

Zealand Pharma conference call on May 16 at 2pm CET (8am ET) to present first quarter 2024 financial results

MT Højgaard Holding A/S: Conference call 16 May at 10.00 CET about Q1 2024

Q3 2023/24 - First sale of the XM30 completed

Novo Nordisk A/S: Trading in Novo Nordisk shares by board members, executives and associated persons

DSV, 1107 - MANAGERS’ TRANSACTIONS IN DSV A/S SHARES

Exploration of options regarding a directed capital increase at market price in Pharma Equity Group A/S

Nykredit Realkredit A/S publishes new prospectus - Nykredit Realkredit A/S

Lollands Bank offentliggør periodemeddelelse for 1. kvartal 2024

Nykredit Realkredit A/S publishes Euro Medium Term Note Programme - Nykredit Realkredit A/S

Extraordinary General Meeting

Vilkår for DLRs auktioner i maj over obligationer til refinansiering af variabelt forrentede CIBOR-lån pr. 1. juli 2024

Interim Report Q1 2024

Svitzer Completes Tug Series Delivery in Brazil

First Quarter 2024: Strong growth in US sales of The NGAL Test

Bavarian Nordic Announces Interim Results for the First Three Months of 2024

APRIL VOLUMES: FREIGHT GROWTH ACROSS MOST OF NETWORK

NKT A/S Q1 2024 Interim Report: 27% organic growth and investments in Solutions and Applications

Q1 2024 INTERIM REPORT: ON TRACK TO DELIVER ON OUTLOOK

Interim Reports Q1 2024 - Nykredit Realkredit Group

Correction: NTG Nordic Transport Group publishes interim report for Q1 2024

NTG Nordic Transport Group publishes interim report for Q1 2024

Allarity Therapeutics Announces that All Series A Preferred and All Variable Priced Warrants have Converted to Common Stock

Interim report for Q2 and H1 2023/24 (the period 01.10.2023 - 31.03.2024)

Managers’ transactions